Ortin Global Ltd: A Comprehensive Overview

Ortin Global Limited, an India-based company, operates primarily in the health care sector, focusing on the pharmaceuticals industry. The company is engaged in the manufacturing and trading of pharmaceuticals, drugs, and intermediates. Its product range includes a variety of medicines such as ayurvedic, homeopathic, Unani, biochemical, and nature cure products. In addition to its pharmaceutical activities, Ortin Global Ltd is also involved in the real estate business.

Financial Snapshot

As of May 29, 2025, Ortin Global Ltd’s close price stood at 11.61 INR. The company’s stock has experienced significant fluctuations over the past year, with a 52-week high of 24.82 INR recorded on August 25, 2024, and a 52-week low of 9.64 INR on March 27, 2025. The market capitalization of Ortin Global Ltd is currently 95,300,000 INR. However, the company’s price-to-earnings ratio is negative at -11.42, indicating potential challenges in profitability.

Market Presence

Ortin Global Ltd is listed on the National Stock Exchange of India, which serves as its primary exchange. The company’s operations are conducted in Indian Rupees (INR), aligning with its domestic market focus.

Business Operations

The company’s core business revolves around the production and distribution of a diverse range of medicinal products. This includes traditional and alternative medicine categories, reflecting a broad market approach. Additionally, Ortin Global Ltd’s involvement in the real estate sector diversifies its business operations beyond pharmaceuticals.

In summary, Ortin Global Ltd is a multifaceted company with a strong presence in the pharmaceutical industry and a strategic expansion into real estate. Despite facing financial challenges as indicated by its negative P/E ratio, the company continues to operate across various sectors within the health care domain.